Business Wire

Effepharm's UTHEVER® NMN: 66 people Human Clinical Trial Data Published, NAD+/NADH Level increased 38% in 2 months

Share

Effepharm Ltd creatively launched a branded NMN ingredient to bring the purest and safest NMN ingredient around the world. UTHEVER® NMN has been clinically proven to be safe and to improve the NAD+/NADH level in the human body, thus realizing the anti-aging function.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005649/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Figure 1 https://www.frontiersin.org/articles/10.3389/fragi.2922.851698/full (Graphic: Business Wire)

On 5th May 2022, Frontiers in Aging, an authoritative international journal on aging mechanisms, published one NMN clinical trial report with new insights and more experience being brought into the field of longevity.

Frontiers in Aging, one of the largest and highest-cited publishers in the world, led and peer-reviewed by editorial boards of over 100,000 top researchers, agreed to publish UTHEVER® NMN’s human clinical trial report, which was reviewed by scientists, including professors at Harvard Medical School. This is the first time that Effepharm released detailed trial data to the public.

Compared with previous NMN clinical trials involving dozens of people, the number of Effepharm’s UTHEVER® clinical trial was up to 66 people which is more conspicuous. At the end of the study (day 60), the level of NAD+/NADH increased further by 38% from baseline in the UTHEVER® group, compared to a mere 14.3% rise in the placebo group which might be attributed to the placebo effect. HOMA (homeostatic model assessment), 6 minute walking endurance test and SF-36 questionnaire were assessed to show that UTHEVER® has the potential to improve the quality of life and boost the happiness of the subjects under the test conditions.

Moreover, Effepharm as one of the leading manufacturer of NMN, has finished the toxicology tests of Uthever, which proved that Uthever is non-mutagenic and has no acute and sub-chronic toxicity. Although the test results are not publicly available now, they have laid a solid foundation for the evaluation of the safety of UTHEVER® NMN.

Effepharm’s R&D Director Jianjun Yu said: “ The clinical trials of UTHEVER® NMN is to establish a more professional and scientific image, helping the downstream supplement brand side get more power to do product endorsement and give more confidence to end consumers. Up to now, more and more well-known supplement brands such as Prohealth Longevity® in the USA, Do Not Age in UK, Kenay® Agescience, AFEGE Anti-aging Shop, MoleQlar in EU., VitaNAD+ in Japan etc. are using UTHEVER® trademark and realized the co-branding effects.”

Dr. Yu also revealed that the first period of NMN clinical trials mainly aimed to verify the safety of UTHEVER® NMN, so we designed a lower dosage to some extent. In the next few years, we will consider to conduct more NMN function researches to explore the safety of larger doses of NMN and the effectiveness of related indications on which this trial data are based. Effepharm Ltd will also apply for FDA Affirmed GRAS on NMN, which means that NMN raw material through the food regulations of various countries has taken a milestone step.

Reference:

https://www.frontiersin.org/articles/10.3389/fragi.2022.851698/full

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Effepharm Ltd
marketing@effepharm.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

B2Core Reveals Its Latest Updates: What’s New?29.5.2023 17:00:00 EEST | Press release

B2Core, the premier CRM solution trusted by brokers and exchanges around the globe, continues to push the boundaries of innovation with its most recent significant update. This update introduces several advanced features and streamlined operations, giving financial institutions more powerful capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230529005019/en/ Telegram Integration (Graphic: Business Wire) Let's have a look at the most notable features. 1. Advanced Event Notification Module A brand-new Event Notification module has been added to the B2Core Back Office, providing admin users with a vast array of customizable event notifications. With the available 27 choices, administrators may send out alerts for various situations, from withdrawal requests to successful registrations. Notifications are sent out to admin users on time whenever an event occurs, allowing them to respond appropriately. Additionally, the

BLUETTI to Showcase New Power Solutions at The Smarter E Europe Exhibition29.5.2023 13:08:00 EEST | Press release

BLUETTI, a leading provider of energy storage solutions, announced its participation in The Smarter E Europe exhibition from June 14th to June 16th in Munich, Germany. It will display its innovative power stations, including the newly launched mobile power AC180 and AC60&B80, and the upcoming household power system, EP760. The Smarter E Europe, the largest energy exhibition in Europe, offers an ideal platform for BLUETTI to show its latest products and innovations in the renewable energy sector. BLUETTI will be at stand C3.240 in the ees Europe section, alongside the exhibition's other three sections, Power2Drive Europe, EM-Power Europe and the famous Intersolar Europe. BLUETTI's presence at the show underscores its commitment to providing sustainable energy solutions to global audiences that chimes perfectly with the goal of the trade fair: Creating a new energy world. Visitors to the BLUETTI booth can expect to see its broad product portfolio, as well as exciting new additions. Among

GIGABYTE’s AI Servers with Superchips Shine at COMPUTEX, Redefining a New Era of Computing29.5.2023 12:02:00 EEST | Press release

GIGABYTE is exhibiting cutting-edge technologies and solutions at COMPUTEX 2023, presenting the theme “Future of COMPUTING”. From May 30th to June 2nd, GIGABYTE is showcasing over 110 products that are driving future industry transformation, demonstrating the emerging trends of AI technology and sustainability, on the 1st floor, Taipei Nangang Exhibition Center, Hall 1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005657/en/ (Photo: Business Wire) Win Big with AI through GIGABYTE’s Pioneering GPU/HPC Servers GIGABYTE and its subsidiary, Giga Computing, are introducing unparalleled AI/HPC server lineups, leading the era of exascale supercomputing. One of the stars is the industry’s first NVIDIA-certified HGX H100 8-GPU SXM5 server, G593-SD0. Equipped with the 4th Gen Intel Xeon Scalable Processors and GIGABYTE’s industry-leading thermal design, G593-SD0 can perform extremely intensive workloads from generative AI and

UAE’s Falcon 40B Dominates Leaderboard: Ranks #1 Globally in Latest Hugging Face Independent Verification of Open-source AI Models29.5.2023 11:52:00 EEST | Press release

Falcon 40B, the UAE’s first large-scale open-source, 40-billion-parameter AI model launched by Abu Dhabi’s Technology Innovation Institute (TII) last week, soared to the top spot on Hugging Face’s latest Open Large Language Model (LLM) Leaderboard. Hugging Face, an American company seeking to democratize artificial intelligence through open-source and open science, is considered the world’s definitive independent verifier of AI models. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230529005045/en/ Falcon 40B ranks 1st globally in Hugging Face Open LLM Leaderboard. (Graphic: AETOSWire) Falcon 40B managed to beat back established models such as LLaMA from Meta (including its 65B model), StableLM from Stability AI, and RedPajama from Together to achieve the coveted ranking. The index utilizes four key benchmarks from the Eleuther AI Language Model Evaluation Harness, a consolidated framework that assesses generative language m

The Inca Arrives to USA, a Strong Outlook for Peru Tourism Recovery27.5.2023 18:00:00 EEST | Press release

The Inca emperor walks the streets of New York City while his retinue dances tirelessly along the way, garnering the attention of the passers-by who stopped to stare and take video of the captivating scene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230526005330/en/ Peruvian actors from Cusco promoting the Inti Raymi 2023 in New York City, as tourism in Peru is once more on the rise. (Photo: PROMPERÚ). This performance was displayed by 30 actors from Cusco, Peru, as a promotional strategy to get Peru back in the news and in front of potential visitors in a positive way. The upcoming Inti Raymi (Festival of the Sun), a thousand-year-old ritual worshiping the Sun God and asking him to make the days longer, was promoted in the Big Apple in order to put the most notable celebration of Cusco’s calendar in the international spotlight. Inti Raymi honors the Sun each June 24th and celebrates the winter solstice of the Southern H

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom